title: Chimeric antigen receptor T cells for cancer immunotherapy.
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Curran
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY brentjer@mskcc.org.
authors.forename: Renier J
authors.initials: RJ
authors.lastname: Brentjens
mesh_terms: D001859:Bone Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D012509:Sarcoma / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases